You searched for "safety"
The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease
2 August 2024
| Zina Mobarak
|
EYE - Vitreo-Retinal
In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...
Burning vision: vision loss from misuse of ‘toy’ laser pens in children
1 April 2014
| Imran Haq, Naz Raoof, Fahd Quhill
|
EYE - Cornea
A case series of five children with macular burns due to the misuse of novelty laser products, purchased online or abroad, was undertaken at the Royal Hallamshire Hospital and The Children’s Hospital, Sheffield [1]. All patients were from the Sheffield...
Research into headlight glare commissioned by government
The government has commissioned much needed research into the causes of night-time headlight glare, after campaigning involving the College of Optometrists among others. The College spearheaded the lobbying on behalf of the optical sector, in collaboration with colleagues from the...Development of a modern surgical simulation suite to promote safer ophthalmic surgical training
5 August 2020
| David Lockington
|
EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - Orbit, EYE - General
For trainees, having access to surgical simulation equipment is more important than ever. The authors describe the creation of a bespoke teaching and training suite in Glasgow to help trainees develop their skills and promote surgical excellence. Simulation has become...
A unique case of macular burn from ‘toy’ laser
2 February 2024
| Paras Agarwal, Manoj Kulshrestha
|
EYE - General
The first laser was created in 1960 and its name is an acronym for ‘light amplification by stimulated emission of radiation’. Laser technology has been used for medical, industrial, research and entertainment purposes in a variety of fields following extensive...
Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.Setting up successful safe & efficient nurse-led intravitreal injection service
In September 2019, we organised a training course at Great Western NHS Hospital (GWH), Swindon, which provided presentations, discussions and hands-on wet lab experience on how to perform intravitreal injection using intravitreal assisted device (INVITRIA) for nurses and doctors from...Oertli Instrumente AG wins the Swiss Medtech Award
12 June 2024
|
Awards, Conferences & Anniversaries, Company Profiles
Oertli Instrumente AG has been honored with the prestigious Swiss Medtech Award, worth CHF 75,000 at the Swiss Medtech Day.
My Top Five: Promising gene therapies for ocular conditions
4 December 2024
| Ameer Khamise
|
EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...
My Top Five: Promising gene therapies for ocular conditions
4 December 2024
| Ameer Khamise
|
EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...
Heidelberg Engineering supplies free protective breath shields
9 April 2020
|
COVID-19
Heidelberg Engineering has announced that it is shipping protective breath shields free of charge to SPECTRALIS owners in the UK.
